Primary stent implantation for acute myocardial infarction during pregnancy: Use of abciximab, ticlopidine, and aspirin

199861 citationsJournal Article

Authors

Cherian Sebastian · Taranaki Base Hospital

Michael A. Scherlag · University of Oklahoma Health Sciences Center

Aaron D. Kugelmass · University of Oklahoma Health Sciences Center

Eliot Schechter · University of Oklahoma Health Sciences Center

Abstract

Recent evidence suggests that coronary stenting and the use of antiplatelet agents during coronary interventions will improve the outcome of patients with acute myocardial infarction (AMI). We describe the management of AMI in a 30-year-old woman, 38 weeks pregnant, with primary stenting and antiplatelet agents.

Topics & Keywords

Acute Myocardial Infarction Research Coronary Interventions and Diagnostics Cardiovascular Issues in Pregnancy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Catheterization and Cardiovascular Diagnosis

Volume 45, Issue 3, pp. 275-279

DOI: 10.1002/(sici)1097-0304(199811)45:3<275::aid-ccd13>3.0.co;2-q

Field-Weighted Citation Impact: 0.68